Literature DB >> 2390102

Vitamin K epoxide and quinone reductase activities. Evidence for reduction by a common enzyme.

S L Gardill1, J W Suttie.   

Abstract

Vitamin K hydroquinone formation in rat liver can be catalyzed by a thiol-dependent quinone reductase activity which shares several characteristics with the vitamin K 2,3-epoxide reductase activity. The possibility that a single enzyme catalyzes both reductions was investigated. Values of Vmax/Km for several different vitamin K analogs were determined and found to be similar for both reductase activities. Several different coumarins were also shown to achieve 50% inhibition at similar concentrations for both enzyme activities. The chloro analog of menaquinone-2 was shown to inhibit both reductases, and the presence of either the quinone or epoxide form of the vitamin protected both activities from inactivation. Thioredoxin was shown to function as a reductant for both reductase activities, although the maximum enzyme activity achieved by this reductant was only half that achieved with dithiothreitol as a reductant. Cofractionation of the two reductase activities on a variety of column matrices was also observed. These data strongly support the hypothesis that one microsomal enzyme is capable of catalyzing both reduction of vitamin K 2,3-epoxide to the quinone, and the quinone to vitamin K hydroquinone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390102     DOI: 10.1016/0006-2952(90)90493-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

Authors:  J-K Tie; D W Stafford
Journal:  Methods Enzymol       Date:  2016-11-22       Impact factor: 1.600

2.  Functional study of the vitamin K cycle in mammalian cells.

Authors:  Jian-Ke Tie; Da-Yun Jin; David L Straight; Darrel W Stafford
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

Review 3.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Human vitamin K epoxide reductase and its bacterial homologue have different membrane topologies and reaction mechanisms.

Authors:  Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal:  J Biol Chem       Date:  2012-08-24       Impact factor: 5.157

5.  Stimulation of the dithiol-dependent reductases in the vitamin K cycle by the thioredoxin system. Strong synergistic effects with protein disulphide-isomerase.

Authors:  B A Soute; M M Groenen-van Dooren; A Holmgren; J Lundström; C Vermeer
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

6.  Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.

Authors:  Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

Review 7.  Current concepts and controversies in the use of vitamin K.

Authors:  J A Thorp; L Gaston; D R Caspers; M L Pal
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

Review 8.  Relationship between Structure and Biological Activity of Various Vitamin K Forms.

Authors:  Katarzyna Bus; Arkadiusz Szterk
Journal:  Foods       Date:  2021-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.